You are here: Industry Insights > oncology

News List

As Advair generic hits, GSK looks to oncology to spur growth alongside Shingrix, HIV fiercepharma
February 24, 2019
GlaxoSmithKline had several years to prepare for the U.S. generic assault on its respiratory blockbuster Advair, offering discounts and rolling out new therapies to stay in the game.
Lilly closes $8bn Loxo Oncology acquisition pharmaceutical-technology
February 19, 2019
Eli Lilly has completed the acquisition of all outstanding shares of Loxo Oncology in a deal valued at approximately $8bn, boosting its oncology portfolio with precision medicines to potentially treat genomically defined cancers.
Eli Lilly to buy Loxo Oncology for $8 billion expressbpd
January 10, 2019
The deal follows Bristol-Myers Squibb Co agreement last week to buy Celgene Corp for $74 billion, and gives Lilly access to Loxo’s portfolio of targeted medicines that treat cancers caused by rare gene mutations
Forbius Announces the First Patient Dosed in a Phase 1 Oncology Trial of AVID200 americanpharmaceuticalreview
January 10, 2019
Forbius announced the first patient was dosed in a Phase 1 clinical trial with AVID200. The trial will evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor effects of escalating doses of AVID200 in patients with solid tumors.....
AstraZeneca Announces Organizational Changes americanpharmaceuticalreview
January 08, 2019
AstraZeneca has announced organizational changes that include the arrival of oncology scientist, José Baselga.Other changes include the creation of .....
Ex-Novartis Oncology CEO Liz Barrett joins UroGen fiercebiotech
January 04, 2019
Ex-Novartis Oncology CEO Liz Barrett has joined UroGen Pharma. Barrett is taking over as CEO of the uro-oncology specialist at a time when it is working on a rolling NDA that could lead to its first drug approval.....
Relay adds executives to its chemistry, R&D teams as it transitions to the development stage fiercebiotech
January 02, 2019
Former Fierce 15 winner Relay Therapeutics has brought on Verastem’s Mahesh Padval, Ph.D., and Eli Lilly’s Mary Mader, Ph.D., to boost its drug discovery and development operations in oncology as it begins to transition to an R&D-stage biotech.....
Mission Bio reels in $30M for single-cell genomics tech for oncology, CRISPR fiercebiotech
December 26, 2018
Since launching at the end of 2017 with a focus on blood cancers, Mission Bio has built out its single-cell genomics platform to include custom offerings....
Lilly lays out sunny 2019 forecast driven by growth of new diabetes, psoriasis and cancer drugs fiercepharma
December 25, 2018
Shares of Eli Lilly were up nearly 3% in premarket trading on Wednesday after the company provided a revenue and profit forecast for next year that beat analysts’ expectations.
AVEO Oncology Announces Clinical Collaboration with AstraZeneca americanpharmaceuticalreview
December 24, 2018
AVEO Oncology has entered into a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of AstraZeneca's Imfinzi (durvalumab).....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page